-
Je něco špatně v tomto záznamu ?
Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase
V. Vaněk, M. Buděšínský, P. Kabeleová, M. Šanda, M. Kožíšek, I. Hančlová, J. Mládková, J. Brynda, I. Rosenberg, M. Koutmos, T.A. Garrow, J. Jiráček
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem, Research Support, N.I.H., Extramural
- MeSH
- betain-homocystein-S-methyltransferasa antagonisté a inhibitory MeSH
- homocystein analogy a deriváty farmakologie chemická syntéza chemie MeSH
- inhibitory enzymů farmakologie chemická syntéza chemie MeSH
- kyseliny pentanové farmakologie chemická syntéza chemie MeSH
- lidé MeSH
- molekulární struktura MeSH
- racionální návrh léčiv MeSH
- stereoizomerie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to l-homocysteine, yielding dimethylglycine and l-methionine. In this study, we prepared a new series of BHMT inhibitors. The inhibitors were designed to mimic the hypothetical transition state of BHMT substrates and consisted of analogues with NH, N(CH(3)), or N(CH(3))(2) groups separated from the homocysteine sulfur atom by a methylene, ethylene, or a propylene spacer. Only the inhibitor with the N(CH(3)) moiety and ethylene spacer gave moderate inhibition. This result led us to prepare two inhibitors lacking a nitrogen atom in the S-linked alkyl chain: (RS,RS)-5-(3-amino-3-carboxypropylthio)-3-methylpentanoic acid and (RS)-5-(3-amino-3-carboxypropylthio)-3,3-dimethylpentanoic acid. Both of these compounds were highly potent inhibitors of BHMT. The finding that BHMT does not tolerate a true betaine mimic within these inhibitors, especially the nitrogen atom, is surprising and evokes questions about putative conformational changes of BHMT upon the binding of the substrates/products and inhibitors.
- 000
- 03229naa 2200529 a 4500
- 001
- bmc11016859
- 003
- CZ-PrNML
- 005
- 20121113101644.0
- 008
- 110628s2009 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vaněk, Václav. $7 _AN044668
- 245 10
- $a Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase / $c V. Vaněk, M. Buděšínský, P. Kabeleová, M. Šanda, M. Kožíšek, I. Hančlová, J. Mládková, J. Brynda, I. Rosenberg, M. Koutmos, T.A. Garrow, J. Jiráček
- 314 __
- $a Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 520 9_
- $a Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to l-homocysteine, yielding dimethylglycine and l-methionine. In this study, we prepared a new series of BHMT inhibitors. The inhibitors were designed to mimic the hypothetical transition state of BHMT substrates and consisted of analogues with NH, N(CH(3)), or N(CH(3))(2) groups separated from the homocysteine sulfur atom by a methylene, ethylene, or a propylene spacer. Only the inhibitor with the N(CH(3)) moiety and ethylene spacer gave moderate inhibition. This result led us to prepare two inhibitors lacking a nitrogen atom in the S-linked alkyl chain: (RS,RS)-5-(3-amino-3-carboxypropylthio)-3-methylpentanoic acid and (RS)-5-(3-amino-3-carboxypropylthio)-3,3-dimethylpentanoic acid. Both of these compounds were highly potent inhibitors of BHMT. The finding that BHMT does not tolerate a true betaine mimic within these inhibitors, especially the nitrogen atom, is surprising and evokes questions about putative conformational changes of BHMT upon the binding of the substrates/products and inhibitors.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a betain-homocystein-S-methyltransferasa $x antagonisté a inhibitory $7 D050940
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a inhibitory enzymů $x farmakologie $x chemická syntéza $x chemie $7 D004791
- 650 _2
- $a homocystein $x analogy a deriváty $x farmakologie $x chemická syntéza $x chemie $7 D006710
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a kyseliny pentanové $x farmakologie $x chemická syntéza $x chemie $7 D010421
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Buděšínský, Miloš, $d 1944- $7 jn20010309100
- 700 1_
- $a Kabeleová, Petra $7 xx0110456
- 700 1_
- $a Šanda, Miloslav. $7 xx0210970
- 700 1_
- $a Kožíšek, Milan $7 xx0100179
- 700 1_
- $a Hančlová, Ivona $7 xx0106064
- 700 1_
- $a Mládková, Jana. $7 _AN059447
- 700 1_
- $a Brynda, Jiří $7 xx0100180
- 700 1_
- $a Rosenberg, Ivan, $d 1948- $7 xx0086095
- 700 1_
- $a Koutmos, Markos
- 700 1_
- $a Garrow, Timothy A.
- 700 1_
- $a Jiráček, Jiří, $d 1965- $7 xx0098873
- 773 0_
- $t Journal of Medicinal Chemistry $w MED00010049 $g Roč. 52, č. 12 (2009), s. 3652-3665
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110720122333 $b ABA008
- 991 __
- $a 20121113101659 $b ABA008
- 999 __
- $a ok $b bmc $g 864099 $s 726651
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00010049 $b 52 $c 12 $d 3652-3665 $m Journal of medicinal chemistry $n J Med Chem
- LZP __
- $a 2011-3B09/BBjvme